Bio Path Holdings Said May Offer And Sell Up To $2M Of Common Stock From Time To Time Through HC Wainwright; Entered Into At Market Offering Agreement Relating To Shares Of Common Stock Offered By Prospectus Supplement
Portfolio Pulse from Charles Gross
Bio Path Holdings plans to offer and sell up to $2M of common stock intermittently through HC Wainwright, based on an at-market offering agreement and a prospectus supplement.
April 04, 2024 | 8:40 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bio Path Holdings is set to offer and sell up to $2M of its common stock through HC Wainwright, which could dilute current shareholders but provide the company with additional capital.
The offering of up to $2M in common stock by Bio Path Holdings could lead to dilution of existing shares, typically resulting in a negative short-term impact on the stock price. However, the additional capital raised could benefit the company's financial position and future growth prospects.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100